Sustainable production of 2,3,5,6-Tetramethylpyrazine at high titer in engineered Corynebacterium glutamicum
Journal of Industrial Microbiology and Biotechnology · 2024
DOI: 10.1093/jimb/kuae026 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Industrial Microbiology and Biotechnology, 2024. Verfasst von Aparajitha Srinivasan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Joint BioEnergy Institute, Emeryville, CA 94608, USA. Hauptthemen laut MEDLINE: Corynebacterium glutamicum, Pyrazines, Metabolic Engineering, Culture Media. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: U.S. Department of Energy, Department of Energy-BioEnergy Technologies Office.
Abstract (Originalsprache)
The industrial amino acid production workhorse, Corynebacterium glutamicum naturally produces low levels of 2,3,5,6-tetramethylpyrazine (TMP), a valuable flavor, fragrance, and commodity chemical. Here, we demonstrate TMP production (∼0.8 g L−1) in C. glutamicum type strain ATCC13032 via overexpression of acetolactate synthase and/or α-acetolactate decarboxylase from Lactococcus lactis in CGXII minimal medium supplemented with 40 g L−1 glucose. This engineered strain also demonstrated growth and TMP production when the minimal medium was supplemented with up to 40% (v v−1) hydrolysates derived from ionic liquid-pretreated sorghum biomass. A key objective was to take the fully engineered strain developed in this study and interrogate medium parameters that influence the production of TMP, a critical post-strain engineering optimization. Design of experiments in a high-throughput plate format identified glucose, urea, and their ratio as significant components affecting TMP production. These two components were further optimized using response surface methodology. In the optimized CGXII medium, the engineered strain could produce up to 3.56 g L−1 TMP (4-fold enhancement in titers and 2-fold enhancement in yield, mol mol−1) from 80 g L−1 glucose and 11.9 g L−1 urea in shake flask batch cultivation. One-Sentence Summary Corynebacterium glutamicum was metabolically engineered to produce 2,3,5,6-tetramethylpyrazine followed by a design of experiments approach to optimize medium components for high-titer production.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Joint BioEnergy Institute, Emeryville, CA 94608, USA.
- Biological Systems and Engineering Division, Lawrence Berkeley National Laboratory, Berkeley, CA 94720, USA.
- Advanced Biofuels and Bioproducts Process Development Unit, Emeryville, CA 94608, USA.
- Environmental Genomics & Systems Biology Division, Lawrence Berkeley National Laboratory, Berkeley, CA 94720, USA.
ORCID-Profile: Aparajitha Srinivasan, Deepanwita Banerjee, Venkataramana R Pidatala, Aymerick Eudes, Blake A Simmons, Thomas Eng, Aindrila Mukhopadhyay
Förderung
- U.S. Department of Energy
- Department of Energy-BioEnergy Technologies Office
Zitieren
APA
Srinivasan, A., Chen-Xiao, K., Banerjee, D., Oka, A., Pidatala, V. R., Eudes, A., Simmons, B. A., Eng, T., & Mukhopadhyay, A. (2024). Sustainable production of 2,3,5,6-Tetramethylpyrazine at high titer in engineered Corynebacterium glutamicum. Journal of Industrial Microbiology and Biotechnology. https://doi.org/10.1093/jimb/kuae026
Vancouver
Srinivasan A, Chen-Xiao K, Banerjee D, Oka A, Pidatala VR, Eudes A, et al. Sustainable production of 2,3,5,6-Tetramethylpyrazine at high titer in engineered Corynebacterium glutamicum. Journal of Industrial Microbiology and Biotechnology. 2024. doi:10.1093/jimb/kuae026
BibTeX
@article{Srinivasan2024,
author = {Srinivasan, Aparajitha and Chen-Xiao, Kevin and Banerjee, Deepanwita and Oka, Asun and Pidatala, Venkataramana R and Eudes, Aymerick and Simmons, Blake A and Eng, Thomas and Mukhopadhyay, Aindrila},
title = {Sustainable production of 2,3,5,6-Tetramethylpyrazine at high titer in engineered Corynebacterium glutamicum},
journal = {Journal of Industrial Microbiology and Biotechnology},
year = {2024},
doi = {10.1093/jimb/kuae026}
}
EUVIMED